Nome |
# |
Noble metals in medicine: Latest advances, file e2f56eda-c32c-3eaf-e053-3a05fe0a5d97
|
582
|
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one, file e2f56ed4-ffa6-3eaf-e053-3a05fe0a5d97
|
346
|
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead, file e2f56ed8-d367-3eaf-e053-3a05fe0a5d97
|
272
|
Gold nanoparticles: A new golden Era in oncology?, file e2f56ed9-a939-3eaf-e053-3a05fe0a5d97
|
203
|
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions, file e2f56ed4-eff7-3eaf-e053-3a05fe0a5d97
|
199
|
Arsenic toxicity: Molecular targets and therapeutic agents, file e2f56ed8-df2b-3eaf-e053-3a05fe0a5d97
|
142
|
The aging kidney—as influenced by heavy metal exposure and selenium supplementation, file e2f56eda-90dd-3eaf-e053-3a05fe0a5d97
|
89
|
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator, file e2f56ed9-72b4-3eaf-e053-3a05fe0a5d97
|
82
|
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach, file e2f56eda-4db3-3eaf-e053-3a05fe0a5d97
|
36
|
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases, file e2f56ed9-b7b7-3eaf-e053-3a05fe0a5d97
|
19
|
Substituent effects on ionization constants as a predictive tool of coordinating ability, file e2f56ed5-000d-3eaf-e053-3a05fe0a5d97
|
16
|
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators, file e2f56ed4-eff5-3eaf-e053-3a05fe0a5d97
|
7
|
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline), file e2f56ed3-c30c-3eaf-e053-3a05fe0a5d97
|
6
|
Silver coordination compounds: A new horizon in medicine, file e2f56eda-c32b-3eaf-e053-3a05fe0a5d97
|
6
|
Preface, file e2f56ed3-8a22-3eaf-e053-3a05fe0a5d97
|
5
|
null, file e2f56ed3-9dcf-3eaf-e053-3a05fe0a5d97
|
5
|
Nickel binding sites in histone proteins: spectroscopic and structural characterization, file e2f56ed3-a7b1-3eaf-e053-3a05fe0a5d97
|
5
|
null, file e2f56ed3-b2e8-3eaf-e053-3a05fe0a5d97
|
5
|
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives, file e2f56ed3-b764-3eaf-e053-3a05fe0a5d97
|
5
|
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites, file e2f56ed4-f17e-3eaf-e053-3a05fe0a5d97
|
5
|
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study, file e2f56ed4-f28e-3eaf-e053-3a05fe0a5d97
|
5
|
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds, file e2f56ed5-a627-3eaf-e053-3a05fe0a5d97
|
5
|
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite, file e2f56ed7-c75d-3eaf-e053-3a05fe0a5d97
|
5
|
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation, file e2f56ed8-a56c-3eaf-e053-3a05fe0a5d97
|
5
|
null, file e2f56ed3-a738-3eaf-e053-3a05fe0a5d97
|
4
|
null, file e2f56ed3-ace3-3eaf-e053-3a05fe0a5d97
|
4
|
null, file e2f56ed5-bd6d-3eaf-e053-3a05fe0a5d97
|
4
|
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan, file e2f56ed6-0d57-3eaf-e053-3a05fe0a5d97
|
4
|
Manganese and cobalt binding in a multi-histidinic fragment, file e2f56ed3-8ae7-3eaf-e053-3a05fe0a5d97
|
3
|
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study, file e2f56ed3-9064-3eaf-e053-3a05fe0a5d97
|
3
|
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates, file e2f56ed3-c45a-3eaf-e053-3a05fe0a5d97
|
3
|
Different approaches to the study of chelating agents for iron and aluminium overload pathologies, file e2f56ed4-f003-3eaf-e053-3a05fe0a5d97
|
3
|
null, file e2f56ed4-f42f-3eaf-e053-3a05fe0a5d97
|
3
|
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic, file e2f56ed6-b114-3eaf-e053-3a05fe0a5d97
|
3
|
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies, file e2f56ed7-c756-3eaf-e053-3a05fe0a5d97
|
3
|
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II), file e2f56ed8-010b-3eaf-e053-3a05fe0a5d97
|
3
|
The Potential Clinical Properties of Magnesium, file e2f56ed9-bbbf-3eaf-e053-3a05fe0a5d97
|
3
|
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions, file e2f56ed3-9053-3eaf-e053-3a05fe0a5d97
|
2
|
Warns against unapproved ‘chelation therapy’, file e2f56ed3-9063-3eaf-e053-3a05fe0a5d97
|
2
|
The meaning of aluminium exposure on human health and aluminium-related diseases, file e2f56ed3-9ac3-3eaf-e053-3a05fe0a5d97
|
2
|
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids, file e2f56ed3-a0de-3eaf-e053-3a05fe0a5d97
|
2
|
Copper uptake and trafficking in the brain, file e2f56ed3-a166-3eaf-e053-3a05fe0a5d97
|
2
|
Chelating agents for human diseases related to aluminium overload, file e2f56ed3-ad15-3eaf-e053-3a05fe0a5d97
|
2
|
A family of hydroxypyrone ligands designed and synthesized for iron chelators, file e2f56ed3-aebc-3eaf-e053-3a05fe0a5d97
|
2
|
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity, file e2f56ed3-bb92-3eaf-e053-3a05fe0a5d97
|
2
|
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III), file e2f56ed3-bf27-3eaf-e053-3a05fe0a5d97
|
2
|
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II), file e2f56ed3-c592-3eaf-e053-3a05fe0a5d97
|
2
|
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)], file e2f56ed3-c6c2-3eaf-e053-3a05fe0a5d97
|
2
|
Chelation therapy for metal intoxication. Comments from a thermodynamic view point, file e2f56ed3-c7ee-3eaf-e053-3a05fe0a5d97
|
2
|
null, file e2f56ed3-d63e-3eaf-e053-3a05fe0a5d97
|
2
|
Chemical equilibria in waste-waters during toxic metal ion removal by agricultural biomass, file e2f56ed3-d7a2-3eaf-e053-3a05fe0a5d97
|
2
|
Do anti-diabetic drugs act as copper ligands?, file e2f56ed4-266f-3eaf-e053-3a05fe0a5d97
|
2
|
Chemical features of in use and in progress chelators for iron overload, file e2f56ed5-addc-3eaf-e053-3a05fe0a5d97
|
2
|
null, file e2f56ed5-be5d-3eaf-e053-3a05fe0a5d97
|
2
|
null, file e2f56ed5-c6fc-3eaf-e053-3a05fe0a5d97
|
2
|
null, file e2f56ed5-c854-3eaf-e053-3a05fe0a5d97
|
2
|
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+, file e2f56ed7-a26b-3eaf-e053-3a05fe0a5d97
|
2
|
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays, file e2f56ed8-2341-3eaf-e053-3a05fe0a5d97
|
2
|
Anomalies of the oral cavity in newborns, file 845148c5-ef2e-40cb-92b9-6dc3a5004b98
|
1
|
Thermodynamic remarks on chelating ligands for aluminium related diseases, file e2f56ed3-7a1e-3eaf-e053-3a05fe0a5d97
|
1
|
State of art in the treatment of metal toxicity, file e2f56ed3-8a26-3eaf-e053-3a05fe0a5d97
|
1
|
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate, file e2f56ed3-8d3d-3eaf-e053-3a05fe0a5d97
|
1
|
Kojic derivatives: a promising class of iron(III) chelators, file e2f56ed3-92d5-3eaf-e053-3a05fe0a5d97
|
1
|
Coordination Chemistry Reviews, European Group of Thermodynamics of Metal Complexes
, file e2f56ed3-93af-3eaf-e053-3a05fe0a5d97
|
1
|
Iron chelating agents for iron overload diseases, file e2f56ed3-9e47-3eaf-e053-3a05fe0a5d97
|
1
|
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands, file e2f56ed3-ac61-3eaf-e053-3a05fe0a5d97
|
1
|
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites, file e2f56ed3-bdd7-3eaf-e053-3a05fe0a5d97
|
1
|
State of art in chelating agents for the clinical treatment of metal poisoning, file e2f56ed3-be3d-3eaf-e053-3a05fe0a5d97
|
1
|
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III), file e2f56ed3-be48-3eaf-e053-3a05fe0a5d97
|
1
|
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates, file e2f56ed3-c458-3eaf-e053-3a05fe0a5d97
|
1
|
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates, file e2f56ed3-c459-3eaf-e053-3a05fe0a5d97
|
1
|
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O, file e2f56ed3-c576-3eaf-e053-3a05fe0a5d97
|
1
|
Copper-related diseases: From chemistry to molecular pathology, file e2f56ed4-eeb2-3eaf-e053-3a05fe0a5d97
|
1
|
Kill or cure: Misuse of chelation therapy for human diseases, file e2f56ed4-f062-3eaf-e053-3a05fe0a5d97
|
1
|
Metal ions in the pathogenesis of Alzheimer’s disease: an open field, file e2f56ed4-f4d5-3eaf-e053-3a05fe0a5d97
|
1
|
A Chemometric analysis of metal ion content in Sardinian wines, file e2f56ed5-2a90-3eaf-e053-3a05fe0a5d97
|
1
|
Multiple Sclerosis and environmental factors., file e2f56ed5-71f3-3eaf-e053-3a05fe0a5d97
|
1
|
Chelating agents for metal intoxication, file e2f56ed5-becc-3eaf-e053-3a05fe0a5d97
|
1
|
Metal ion toxicity, file e2f56ed5-c339-3eaf-e053-3a05fe0a5d97
|
1
|
Chelating agents as therapeutic compounds - Basic principles, file e2f56ed5-c8fd-3eaf-e053-3a05fe0a5d97
|
1
|
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions, file e2f56ed6-cb5f-3eaf-e053-3a05fe0a5d97
|
1
|
Toxicity of nanoparticles: etiology and mechanisms, file e2f56ed6-d06e-3eaf-e053-3a05fe0a5d97
|
1
|
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips, file e2f56ed7-0eb3-3eaf-e053-3a05fe0a5d97
|
1
|
Editorial: Applications of Medicinal Bioinorganic Chemistry, file e2f56ed7-5db9-3eaf-e053-3a05fe0a5d97
|
1
|
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine, file e2f56ed7-659e-3eaf-e053-3a05fe0a5d97
|
1
|
Conclusions and guidelines for future research, file e2f56ed7-8303-3eaf-e053-3a05fe0a5d97
|
1
|
Looking at new ligands for chelation therapy, file e2f56ed7-a969-3eaf-e053-3a05fe0a5d97
|
1
|
Study of the Copper(II) -Aztreonam system by potentiometry and spectrophotometry, file e2f56ed7-e9fa-3eaf-e053-3a05fe0a5d97
|
1
|
The essential metals for humans: a brief overview, file e2f56ed8-0c1e-3eaf-e053-3a05fe0a5d97
|
1
|
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology, file e2f56ed8-0c21-3eaf-e053-3a05fe0a5d97
|
1
|
Iron Chelation for Iron Overload in Thalassemia, file e2f56ed8-2705-3eaf-e053-3a05fe0a5d97
|
1
|
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications, file e2f56ed8-6cb6-3eaf-e053-3a05fe0a5d97
|
1
|
Uneven element distribution in alcoholic liver disease. A case report, file e2f56ed8-fc73-3eaf-e053-3a05fe0a5d97
|
1
|
Totale |
2.175 |